search
Back to results

The Diabetes Patient-Reported Outcome Measures Trial (DiaPROM)

Primary Purpose

Diabetes Mellitus, Type 1

Status
Withdrawn
Phase
Not Applicable
Locations
Norway
Study Type
Interventional
Intervention
PAID in clinical diabetes consultations
Sponsored by
Haukeland University Hospital
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional other trial for Diabetes Mellitus, Type 1 focused on measuring Diabetes-related distress, Living with diabetes, Patient-Reported Outcome Measures (PROMs)

Eligibility Criteria

18 Years - 39 Years (Adult)All SexesDoes not accept healthy volunteers
  1. Inclusion Criteria:

    • type 1 diabetes for more than one year
  2. Exclusion Criteria:

    1. not being able to read and complete questionnaires on the computer because of

      • language problems
      • reading problems
      • cognitive problems
    2. pregnancy
    3. severe somatic and psychiatric co-morbidities

Sites / Locations

  • Haukeland University Hospital

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

No Intervention

Arm Label

PAID in clinical diabetes consultations

Control group

Arm Description

Participants randomised to the intervention arm. Participants complete the Problem Area in Diabetes scale (PAID) and evaluation PROMs. Participants with specified PAID scores will be offered an empowerment-based follow-up by diabetes specialist nurses.

Participants randomised to the control group. Participants complete PROMs but the results/answers will not be available in the electronic patient records until the trial is finished. The participants will receive standard care.

Outcomes

Primary Outcome Measures

Change in Diabetes Distress Scale (DDS)
Self reported diabetes-related distress. 17 items are scored on a 6 point Likert scale from 1 "not a problem" to 6 "very serious problem". Scores are summated and divided by 17 to form a mean/average score. There are also four subscales; emotional burden (5 items), physician-related distress (4 items), regimen-related distress (5 items) and interpersonal distress (3 items). The subscale scores are calculated similar to the total score except for dividing by the number of items for each subscale. A total DDS-score or subscale score of more than 3 is regarded as high degree of diabetes distress. Whilst a score of 2 indicate moderate diabetes distress and a score of 1 is considered as low degree of diabetes distress.

Secondary Outcome Measures

Change in The World Health Organisation 5-wellbeing scale (WHO-5)
Self reported emotional wellbeing. 5 items are scored on a 6 point Likert scale from 0 "never" to 5 "all of the time". Scores are summated. Raw score 0 to 25 is transformed to 0-100 by multiplying by 4. Higher values represent better outcome. A score of 50 or below is indicate suboptimal well-being. A score of 28 or below is considered as likely depression.
Change in Perceived Competence for Diabetes Scale (PCDS)
Self report of the individuals perceptions of competence for diabetes. 4 items are scored on a 7 point Likert scale from 1 "strongly disagree" to 7 "strongly agree". Scores are summated and divided by 4 to form a mean/average score. Higher score indicate better perceived diabetes competence.
Change in Glycosylated hemoglobin A1c (HbA1c)
Blood test: HbA1c refers to glycated hemoglobin, which identifies average plasma glucose concentration. Higher values indicate worse outcome.

Full Information

First Posted
February 22, 2018
Last Updated
May 11, 2021
Sponsor
Haukeland University Hospital
Collaborators
Western Norway University of Applied Sciences, University of Bergen
search

1. Study Identification

Unique Protocol Identification Number
NCT03471104
Brief Title
The Diabetes Patient-Reported Outcome Measures Trial
Acronym
DiaPROM
Official Title
The Use of Patient-Reported Outcome Measures (PROMs) to Promote Quality of Clinical Diabetes Consultations
Study Type
Interventional

2. Study Status

Record Verification Date
October 2020
Overall Recruitment Status
Withdrawn
Why Stopped
We have piloted the trial and concluded not to proceed to a fullscale trial.
Study Start Date
January 15, 2018 (Actual)
Primary Completion Date
December 31, 2022 (Anticipated)
Study Completion Date
December 31, 2023 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Haukeland University Hospital
Collaborators
Western Norway University of Applied Sciences, University of Bergen

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The study aim to evaluate the use of Patient-Reported Outcome Measures in clinical diabetes consultations.
Detailed Description
The psychological and emotional impact of living with diabetes is greatly underreported in clinical diabetes care, and diabetes distress is found to be associated with decreased glycemic control. Therefore, regular assessment of diabetes distress is recommended. The integration of assessments with Patient-Reported Outcome Measures (PROMs) in clinical practice has the potential to enhance care for people with diabetes by identifying problems and improving patient-clinician communication. The overall aim of the DiaPROM trial is to develop, test and evaluate the effectiveness of a structured empowerment-based intervention with the use of a PROM regarding diabetes distress as a tool for needs assessment and dialogue support in clinical diabetes consultations among adults with Type 1 Diabetes. The investigator's hypothesis is that the intervention primarily will reduce diabetes distress and secondarily improve overall well-being, improve the perceived competence for diabetes management, improve glycemic control, and improve satisfaction with the diabetes follow-up.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Diabetes Mellitus, Type 1
Keywords
Diabetes-related distress, Living with diabetes, Patient-Reported Outcome Measures (PROMs)

7. Study Design

Primary Purpose
Other
Study Phase
Not Applicable
Interventional Study Model
Sequential Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
0 (Actual)

8. Arms, Groups, and Interventions

Arm Title
PAID in clinical diabetes consultations
Arm Type
Experimental
Arm Description
Participants randomised to the intervention arm. Participants complete the Problem Area in Diabetes scale (PAID) and evaluation PROMs. Participants with specified PAID scores will be offered an empowerment-based follow-up by diabetes specialist nurses.
Arm Title
Control group
Arm Type
No Intervention
Arm Description
Participants randomised to the control group. Participants complete PROMs but the results/answers will not be available in the electronic patient records until the trial is finished. The participants will receive standard care.
Intervention Type
Other
Intervention Name(s)
PAID in clinical diabetes consultations
Other Intervention Name(s)
DiaPROM
Intervention Description
The intervention starts when participants complete PROMs before an annual consultation. The physician reviews the PAID (problem areas in diabetes scale) scores with the participant. Participants with one or more single PAID item(s) scored 3 or 4, or a PAID score ≥30, will be referred to extra follow-up which will consist of at least two diabetes nurse consultations. The nurses will follow a communication manual based on key elements from empowerment theory and self-determination theory. The participants then complete the PROMs prior to the next annual consultation with the physician.
Primary Outcome Measure Information:
Title
Change in Diabetes Distress Scale (DDS)
Description
Self reported diabetes-related distress. 17 items are scored on a 6 point Likert scale from 1 "not a problem" to 6 "very serious problem". Scores are summated and divided by 17 to form a mean/average score. There are also four subscales; emotional burden (5 items), physician-related distress (4 items), regimen-related distress (5 items) and interpersonal distress (3 items). The subscale scores are calculated similar to the total score except for dividing by the number of items for each subscale. A total DDS-score or subscale score of more than 3 is regarded as high degree of diabetes distress. Whilst a score of 2 indicate moderate diabetes distress and a score of 1 is considered as low degree of diabetes distress.
Time Frame
Baseline, 12 months and 24 months.
Secondary Outcome Measure Information:
Title
Change in The World Health Organisation 5-wellbeing scale (WHO-5)
Description
Self reported emotional wellbeing. 5 items are scored on a 6 point Likert scale from 0 "never" to 5 "all of the time". Scores are summated. Raw score 0 to 25 is transformed to 0-100 by multiplying by 4. Higher values represent better outcome. A score of 50 or below is indicate suboptimal well-being. A score of 28 or below is considered as likely depression.
Time Frame
Baseline, 12 months and 24 months.
Title
Change in Perceived Competence for Diabetes Scale (PCDS)
Description
Self report of the individuals perceptions of competence for diabetes. 4 items are scored on a 7 point Likert scale from 1 "strongly disagree" to 7 "strongly agree". Scores are summated and divided by 4 to form a mean/average score. Higher score indicate better perceived diabetes competence.
Time Frame
Baseline, 12 months and 24 months.
Title
Change in Glycosylated hemoglobin A1c (HbA1c)
Description
Blood test: HbA1c refers to glycated hemoglobin, which identifies average plasma glucose concentration. Higher values indicate worse outcome.
Time Frame
Baseline, 12 months and 24 months.

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
39 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: type 1 diabetes for more than one year Exclusion Criteria: not being able to read and complete questionnaires on the computer because of language problems reading problems cognitive problems pregnancy severe somatic and psychiatric co-morbidities
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Anne Haugstvedt, PhD
Organizational Affiliation
Haukeland UH
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Marit Graue, PhD
Organizational Affiliation
Western Norway University of Applied Sciences
Official's Role
Study Chair
First Name & Middle Initial & Last Name & Degree
Ragnhild B. Strandberg, PhD
Organizational Affiliation
Western Norway University of Applied Sciences
Official's Role
Study Chair
First Name & Middle Initial & Last Name & Degree
Grethe S. Tell, PhD
Organizational Affiliation
University of Bergen
Official's Role
Study Chair
First Name & Middle Initial & Last Name & Degree
Ingvild Hernar, MSc
Organizational Affiliation
University of Bergen, Haukeland UH, Western Norway Uni. of Applied Sciences
Official's Role
Study Chair
Facility Information:
Facility Name
Haukeland University Hospital
City
Bergen
State/Province
Hordaland
ZIP/Postal Code
5021
Country
Norway

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
30782722
Citation
Haugstvedt A, Hernar I, Strandberg RB, Richards DA, Nilsen RM, Tell GS, Graue M. Use of patient-reported outcome measures (PROMs) in clinical diabetes consultations: study protocol for the DiaPROM randomised controlled trial pilot study. BMJ Open. 2019 Jan 17;9(1):e024008. doi: 10.1136/bmjopen-2018-024008.
Results Reference
background
PubMed Identifier
33853796
Citation
Hernar I, Graue M, Richards DA, Strandberg RB, Nilsen RM, Rekdal M, Lovaas KF, Madsen TV, Tell GS, Haugstvedt A. Use of patient-reported outcome measures (PROMs) in clinical diabetes consultations: the DiaPROM randomised controlled pilot trial. BMJ Open. 2021 Apr 14;11(4):e042353. doi: 10.1136/bmjopen-2020-042353.
Results Reference
background
PubMed Identifier
33547702
Citation
Hernar I, Graue M, Strandberg RB, Lie SS, Sigurdardottir AK, Richards DA, Kolltveit BH, Haugstvedt A. Young adults with type 1 diabetes and their experiences with diabetes follow-up and participation in the DiaPROM pilot trial: A qualitative study. Diabet Med. 2021 Jun;38(6):e14535. doi: 10.1111/dme.14535. Epub 2021 Feb 16.
Results Reference
background

Learn more about this trial

The Diabetes Patient-Reported Outcome Measures Trial

We'll reach out to this number within 24 hrs